Eclinical Solutions Market: Cloud-Based Segment Is Anticipated To Exhibit An Exponential CAGR Of 15.1%

 eClinical Solutions Industry Overview

The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.

 

As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.

 


eClinical Solutions Market Segmentation

Grand View Research has segmented the global eClinical solutions market on the basis of product, delivery mode, development phase, end-use, and region:

Based on the Printer Product Insights, the market is segmented into Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS), Clinical Analytics Platforms, Randomization and Trial Supply Management (RTSM) Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, and Electronic Trial Master File (eTMF).

  • The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 21.0% in 2021. eCOA is estimated to be the fastest-growing segment during the forecast period owing to the rising significance of high-quality clinical data. eCOA facilitates the preservation of overall quality and is being increasingly incorporated in the measurement of patient-reported, clinician-reported, and observer-reported
  • Soaring need for patient compliance is further pushing the usage of eCOA solutions, which can effectively meet challenges posed by paper-based records. Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. These aforementioned benefits are expected to fuel its demand in the coming years.

 

Based on the Printer Delivery Mode Insights, the market is segmented into Web-hosted (On-Demand), Licensed Enterprise (On-premise), and Cloud-based.

  • The web-hosted segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 74.0% in 2021. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required.
  • The cloud-based segment is anticipated to exhibit an exponential CAGR of 15.1% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring.

 

Based on the Printer Development Phase Insights, the market is segmented into Phase I, Phase II, Phase III, and Phase IV.

  • The phase III segment dominated the eClinical solutions market and accounted for the largest revenue share of over 53.0% in 2021. Spiraling needs for incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.
  • The phase I segment is estimated to be the most promising segment during the forecast period owing to the high significance of these systems to predict future outcomes and eliminate drug candidates possessing the least probability of success. Developments in biological modeling systems and personalized medicinetechnologies are leading to a boom in the development of newer drugs.

 

Based on the Printer End-use Insights, the market is segmented into Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, and Medical Device Manufacturers.

  • The CROs segment dominated the market for eClinical solutions and held the largest revenue share of over 36% in 2021. The segment is projected to rise at a remarkable CAGR during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure.
  • The pharma and biotech organizations segment is expected to witness significant growth over the forecast period. This is attributed to the increasing adoption of eClinical solutions by researchers that provide improved clinical trials and streamlined research workload.

 

eClinical Solutions Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies Profile & Market Share Insights

The key players are involved in various growth strategies such as new product development, mergers and acquisitions, and collaborations, which are helping them consolidate their position in the market. In January 2021, Parexel International Corporation collaborated with Signify Health for offering new solutions to their customers for enabling access to a more diverse and traditionally underrepresented population for their clinical trials. Furthermore, in December 2020, ERT and Bioclinica announced their merger. The merger is aimed at making ERT and Bioclinica leaders in clinical trial endpoint technology.

Some of the prominent players in the eClinical solutions market include:

  • Datatrak International, Inc.
  • Oracle
  • Parexel International Corporation
  • Dassault Systemes
  • Bioclinica
  • CRF Health
  • ERT Clinical
  • eClinicalWorks
  • IBM Watson Health
  • Anju Life Sciences Software
  • eClinical Solutions

 

Order a free sample PDF of the eClinical Solutions Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more